WSI Co., Ltd. Share Price

Equities

A299170

KR7299170001

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 29/04/2024 BST 5-day change 1st Jan Change
1,856 KRW -0.22% Intraday chart for WSI Co., Ltd. -0.80% -16.21%

Financials

Sales 2022 27.13B 19.59M 1.57B Sales 2023 30.88B 22.29M 1.79B Capitalization 66.51B 48.02M 3.85B
Net income 2022 4.37B 3.15M 253M Net income 2023 2.88B 2.08M 166M EV / Sales 2022 1.39 x
Net cash position 2022 18.58B 13.41M 1.07B Net Debt 2023 2.82B 2.04M 163M EV / Sales 2023 2.25 x
P/E ratio 2022
15.8 x
P/E ratio 2023
29.1 x
Employees 27
Yield 2022 *
-
Yield 2023
-
Free-Float 30.25%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.22%
1 week-0.80%
Current month-6.03%
1 month-6.03%
3 months-14.27%
6 months-0.43%
Current year-16.21%
More quotes
1 week
1 839.00
Extreme 1839
1 909.00
1 month
1 811.00
Extreme 1811
2 010.00
Current year
1 811.00
Extreme 1811
2 645.00
1 year
1 750.00
Extreme 1750
2 645.00
3 years
1 505.00
Extreme 1505
3 515.00
5 years
1 505.00
Extreme 1505
5 800.00
10 years
1 505.00
Extreme 1505
5 800.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16/11/20
Comptroller/Controller/Auditor 49 -
Members of the board TitleAgeSince
Chief Executive Officer 58 16/11/20
Director/Board Member 63 -
Director/Board Member 47 -
More insiders
Date Price Change Volume
30/04/24 1,856 -0.22% 39,533
29/04/24 1,860 -0.69% 58,967
26/04/24 1,873 +0.27% 41,160
25/04/24 1,868 -0.11% 33,061
24/04/24 1,870 -0.11% 49,059

End-of-day quote Korea S.E., April 29, 2024

More quotes
WSI Co Ltd, formerly IBKS No.10 Special Purpose Acquisition Co, is a Korea-based company mainly engaged in the sale of pharmaceuticals and medical devices. The Company mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
More about the company
  1. Stock Market
  2. Equities
  3. A299170 Stock